STAT3 and melanoma: Results showed that both parthenolide and TAK-242 dose-dependently lowered protein levels of TLR4, STAT3 and phosphorylated STAT3 (Fig. 6a) in and inhibited the proliferation (Fig. 6b) of A375 and B16 melanoma cells.